Educational paper : Screening in cancer predisposition syndromes: Guidelines for the general pediatrician

European Journal of Pediatrics

Volumn 170, Issue 3, 2011, Pages 285-294

  Teplick, Alexis ^a   Kowalski, Megan ^a   Biegel, Jaclyn A ^b   Nichols, Kim E ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Beckwith Wiedemann syndrome; Cancer predisposition; Genetic testing; Li Fraumeni syndrome; Rhabdoid tumor; Von Hippel Lindau

Indexed keywords

ANTINEOPLASTIC AGENT;

BECKWITH WIEDEMANN SYNDROME; CANCER EPIDEMIOLOGY; CANCER RISK; CANCER SCREENING; CANCER SUSCEPTIBILITY; CHILDHOOD CANCER; CLINICAL EXAMINATION; CLINICAL FEATURE; FAMILIAL CANCER; GENE MUTATION; GENETIC ANALYSIS; HEPATOBLASTOMA; HUMAN; HYPERPLASIA; LABORATORY TEST; NEPHROBLASTOMA; NEURILEMOMA; NEUROFIBROMATOSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIODIAGNOSIS; REVIEW; RHABDOID TUMOR; VON HIPPEL LINDAU DISEASE;

BECKWITH-WIEDEMANN SYNDROME; CHILD; EARLY DETECTION OF CANCER; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LI-FRAUMENI SYNDROME; NEURILEMMOMA; NEUROFIBROMATOSES; RHABDOID TUMOR; SKIN NEOPLASMS; VON HIPPEL-LINDAU DISEASE;

EID: 79954449180     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-010-1377-2     Document Type: Review

References (70)

1. M Baghai GB Thompson WF Young Jr, et al. 2002 Pheochromocytomas and paragangliomas in von Hippel-Lindau disease: a role for laparoscopic and cortical-sparing surgery Arch Surg 137 682 688 12049539 10.1001/archsurg.137.6. 682
2. M Baldisserotto AB Peletti M Angelo de Araújo, et al. 2005 Beckwith-Wiedemann syndrome and bilateral adrenal pheochromocytoma: sonography and MRI findings Pediatr Radiol 35 1132 1134 15983774 10.1007/s00247-005-1518-3 (Pubitemid 41554588)
3. FM Barlaskar GD Hammer 2007 The molecular genetics of adrenocortical carcinoma Rev Endocr Metab Disord 8 343 348 17934868 10.1007/s11154-007-9057-x
4. JB Beckwith 1998 Children at increased risk for Wilms tumor: monitoring issues J Pediatr 132 377 379 9544882 1:STN:280:DyaK1c3gsVCnsQ%3D%3D 10.1016/S0022-3476(98)70001-0 (Pubitemid 28180231)
5. L Bémurat P Gosse P Ballanger, et al. 2002 Successful lapaproscopic operation of bilateral pheochromocytoma in a patient with Beckwith-Wiedemann syndrome J Hum Hypertens 16 281 284 11967723 10.1038/sj.jhh.1001378 (Pubitemid 34441165)
6. J Bliek C Gicquel S Maas, et al. 2004 Epigenotyping as a tool for the prediction of tumor risk and tumor type in patients with Beckwith-Wiedemann syndrome (BWS) J Pediatr 145 796 799 15580204 10.1016/j.jpeds.2004.08.007 (Pubitemid 39586619)
7. JA Biegel J Zhou LB Rorke, et al. 1999 Germ-line and acquired mutations of INI1 in atypical teratoid rhabdoid tumor Cancer Res 59 74 79 9892189 1:CAS:528:DyaK1MXmsFOgsQ%3D%3D (Pubitemid 29062960)
8. JM Birch AL Hartley KJ Tricker, et al. 1994 Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families Cancer Res 54 1298 1304 8118819 1:CAS:528:DyaK2cXitFCjsbY%3D (Pubitemid 24108072)
9. JM Birch RD Alston RJ McNally, et al. 2001 Relative frequency and morphology of cancers in carriers of germline TP53 mutations Oncogene 20 4621 4628 11498785 1:CAS:528:DC%2BD3MXmtFejs7c%3D 10.1038/sj.onc.1204621 (Pubitemid 32762434)
10. C Boyd MJ Smith L Kluwe, et al. 2008 Alterations in the SMARCB1 (INI1) tumor suppressor gene in familial schwannomatosis Clin Genet 74 358 366 18647326 1:CAS:528:DC%2BD1cXhsVyms7zI 10.1111/j.1399-0004.2008.01060.x
11. CS Bruggers SB Bleyl T Pysher, et al. 2010 Clincopathologic comparison of familial versus sporadic atypical teratoid/rhabdoid tumors (AT/RT) of the central nervous system Pediatr Blood Cancer 10.1002/pbc.22757 20848638
12. J Burgess 2010 How should the patient with multiple endocrine neoplasia type 1 (MEN 1) be followed? Clin Endocrinol Oxf 72 13 16 19552677 10.1111/j.1365-2265.2009.03662.x
13. PL Choyke MJ Siegel AW Craft, et al. 1999 Screening for Wilms tumor in children with Beckwith-Wiedemann syndrome or idiopathic hemihypertrophy Med Pediatr Oncol 32 196 200 10064187 1:STN:280:DyaK1M7mtF2msg%3D%3D 10.1002/(SICI)1096-911X(199903)32:3<196::AID-MPO6>3.0.CO;2-9 (Pubitemid 29095979)
14. CL Clericuzio E Chen DE McNeil, et al. 2003 Serum alpha-fetoprotein screening for hepatoblastoma in children with Beckwith-Wiedemann syndrome or isolated hemihyperplasia J Pediatr 143 270 272 12970646 10.1067/S0022-3476(03) 00306-8 (Pubitemid 37082965)
15. PE Clark MS Cookson 2008 The von Hippel-Lindau gene: turning discovery into therapy Cancer 113 1768 1778 18800388 1:CAS:528:DC%2BD1cXht1GqsrjK 10.1002/cncr.23645
16. JA Coleman 2008 Familial and hereditary renal cancer syndromes Urol Clin North Am 35 563 572 18992610 10.1016/j.ucl.2008.07.014
17. WN Cooper A Luharia GA Evans, et al. 2005 Molecular subtypes and phenotypic expression of Beckwith-Wiedemann syndrome Eur J Hum Genet 13 1025 1032 15999116 1:CAS:528:DC%2BD2MXovVOiurc%3D 10.1038/sj.ejhg.5201463 (Pubitemid 43073609)
18. KW Eaton LS Tooke LM Wainwright, et al. 2011 Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors Pediatr Blood Cancer 56 1 7 15 21108436 10.1002/pbc.22831
19. JR Engel A Smallwood A Harper, et al. 2000 Epigenotype-phenotype correlations in Beckwith-Wiedemann syndrome J Med Genet 37 921 926 11106355 1:CAS:528:DC%2BD3MXjsFCnsg%3D%3D 10.1136/jmg.37.12.921 (Pubitemid 32002888)
20. DG Evans P Lunt T Clancy R Eeles 2010 Childhood predictive genetic testing for Li-Fraumeni syndrome Fam Cancer 9 65 69 19404774 1:STN:280:DC%2BC3c7gvFeiug%3D%3D 10.1007/s10689-009-9245-9
21. DB Everman C Shuman B Dzolganovski, et al. 2000 Serum alpha-fetoprotein levels in Beckwith-Wiedemann syndrome J Pediatr 137 123 127 10891834 1:CAS:528:DC%2BD3cXls1Gnu7w%3D 10.1067/mpd.2000.106217 (Pubitemid 30470935)
22. RE Ferner 2010 The neurofibromatoses Pract Neurol 10 82 93 20308235 10.1136/jnnp.2010.206532
23. M Field S Shanley J Kirk 2007 Inherited cancer susceptibility syndromes in paediatric practice J Paediatr Child Health 43 219 229 17444822 10.1111/j.1440-1754.2007.01027.x (Pubitemid 46570079)
24. JM Hilden S Meerbaum P Burger, et al. 2004 Central nervous system atypical teratoid/rhabdoid tumor: results of therapy in children enrolled in a registry J Clin Oncol 22 2877 2884 15254056 10.1200/JCO.2004.07.073 (Pubitemid 41079907)
25. M Hisada JE Garber CY Fung, et al. 1998 Multiple primary cancers in families with Li-Fraumeni syndrome J Natl Cancer Inst 90 606 611 9554443 1:STN:280:DyaK1c3htlWjtA%3D%3D 10.1093/jnci/90.8.606 (Pubitemid 28204804)
26. HE Hoyme LH Seaver KL Jones, et al. 1998 Isolated hemihyperplasia (hemihypertrophy): report of a prospective multicenter study of the incidence of neoplasia and review Am J Med Genet 79 274 278 9781907 1:STN:280: DyaK1cvltlWlug%3D%3D 10.1002/(SICI)1096-8628(19981002)79:4<274::AID- AJMG8>3.0.CO;2-M (Pubitemid 28447108)
27. TJM Hulsebos AS Plomp RA Woterman, et al. 2007 Germline mutation of INI1/SMARCB1 in familial schwannomatosis Am J Hum Genet 80 805 810 17357086 1:CAS:528:DC%2BD2sXktVOis7k%3D 10.1086/513207 (Pubitemid 46564417)
28. SJ Hwang G Lozano CI Amos LC Strong 2003 Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk Am J Hum Genet 72 975 983 12610779 1:CAS:528:DC%2BD3sXivFWgurs%3D 10.1086/374567 (Pubitemid 36403315)
29. EM Jackson TH Shaikh F Zhang, et al. 2007 Atypical teratoid/rhabdoid tumor in a patient with Beckwith-Wiedemann syndrome Am J Med Genet A 143A 1767 1770 17603804 1:CAS:528:DC%2BD2sXpslGmu7c%3D 10.1002/ajmg.a.31843 (Pubitemid 47217276)
30. P Kaatsch E Steliarova-Foucher E Crocetti, et al. 2006 Time trends of cancer incidence in European children (1978-1997): report from the automated childhood cancer information system project Eur J Cancer 42 1961 1971 16919764 10.1016/j.ejca.2006.05.014 (Pubitemid 44224058)
31. HM Katzenstein WB London E Douglass, et al. 2002 Treatment of unresectable and metastatic hepatoblastoma: a pediatric oncology group phase II study J Clin Oncol 20 3438 3444 12177104 10.1200/JCO.2002.07.400
32. HJ Kim JA Butman C Brewer, et al. 2005 Tumors of the endolymphatic sac in patients with von Hippel-Lindau disease: implications for their natural history, diagnosis and treatment J Neurosurg 102 503 512 15796386 10.3171/jns.2005.102.3.0503 (Pubitemid 43194043)
33. P Lapunzina 2005 Risk of tumorigenesis in overgrowth syndromes: a comprehensive review Am J Med Genet 137C 53 71 16010678 10.1002/ajmg.c.30064 (Pubitemid 41113663)
34. CRM Lammens NK Aaronson A Wagner, et al. 2010 Genetic testing in Li-Fraumeni Syndrome: uptake and psychosocial consequences J Clin Oncol 28 3008 3014 20479422 10.1200/JCO.2009.27.2112
35. CRM Lammens EMA Bleiker NK Aaronson, et al. 2010 Regular surveillance for Li-Fraumeni syndrome: advice, adherence and perceived benefits Fam Cancer 9 4 647 654 20658357 1:STN:280:DC%2BC3cbms1OksA%3D%3D 10.1007/s10689-010-9368-z
36. FP Li JF Fraumeni 1982 Prospective study of a family cancer syndrome JAMA 247 2692 2694 7077763 1:STN:280:DyaL387pt1KhtA%3D%3D 10.1001/jama.247.19.2692 (Pubitemid 12105070)
37. RR Lonser GM Glenn M Walther, et al. 2003 von Hippel-Lindau disease Lancet 361 2059 2067 12814730 1:CAS:528:DC%2BD3sXksF2hu7w%3D 10.1016/S0140-6736(03)13643-4 (Pubitemid 36695052)
38. M MacCollin EA Chiocca DG Evans, et al. 2005 Diagnostic criteria for schwannomatosis Neurology 64 1838 1845 15955931 1:STN:280:DC%2BD2MzgvFWmtg%3D%3D 10.1212/01.WNL.0000163982.78900.AD (Pubitemid 40800695)
39. ER Maher JR Yates R Harries, et al. 1990 Clinical features and natural history of von Hippel-Lindau disease Q J Med 77 1151 1163 2274658 1:STN:280:DyaK3M7htVyksQ%3D%3D (Pubitemid 20379533)
40. TJ Manksi DK Heffner GM Glenn, et al. 1997 Endolymphatic sac tumors: a source of morbid hearing loss in von Hippel-Lindau disease JAMA 277 1461 1466 10.1001/jama.277.18.1461 (Pubitemid 27208889)
41. S Masciari AD Van den Abbeele LR Diller 2008 F18-fluorodeoxyglucose- positron emission tomography/computed tomography screening in Li-Fraumeni syndrome JAMA 299 1315 1319 18349092 1:CAS:528:DC%2BD1cXjsV2gtbo%3D 10.1001/jama.299.11.1315 (Pubitemid 351439077)
42. M Meister P Choyke C Anderson U Patel 2009 Radiological evaluation, management and surveillance of renal masses in Von Hippel-Lindau disease Clin Radiol 64 589 600 19414081 1:STN:280:DC%2BD1MzitVymsA%3D%3D 10.1016/j.crad.2008. 10.010
43. RN Moule SG Jhavar RA Eeles 2006 Genotype phenotype correlation in Li-Fraumeni syndrome kindreds and its implications for management Fam Cancer 5 129 133 16736281 1:STN:280:DC%2BD28zgslGrsw%3D%3D 10.1007/s10689-005-4522-8 (Pubitemid 43824468)
44. NCCN (2008) The NCCN Clinical Practice Guidelines in Oncology™ Li-Fraumeni syndrome (Version 1.2008). © 2009 National Comprehensive Cancer Network, Inc. www.nccn.org. Accessed March 15, 2009. To view the most recent and complete version of the NCCN Guidelines, login to http://www.nccn.org
45. HP Neumann BU Bender DP Berger, et al. 1998 Prevalence, morphology and biology of renal cell carcinoma in von Hippel-Lindau disease compared to sporadic renal cell carcinoma J Urol 160 1248 1254 9751329 1:STN:280: DyaK1cvitF2nuw%3D%3D 10.1016/S0022-5347(01)62509-6 (Pubitemid 29480491)
46. Y Oda M Tsuneyoshi 2006 Extrarenal rhabdoid tumors of soft tissue: clinicopathological and molecular genetic review and distinction from other soft-tissue sarcomas with rhabdoid features Pathol Int 56 287 295 16704491 10.1111/j.1440-1827.2006.01962.x (Pubitemid 43725396)
47. M Olivier DE Goldgar N Sodha, et al. 2003 Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype Cancer Res 63 6643 6650 14583457 1:CAS:528:DC%2BD3sXosVGgurs%3D (Pubitemid 37322942)
48. G Perilongo E Shafford R Maibach 2004 Risk-adapted treatment for childhood hepatoblastoma. Final report of the second study of the International Society of Paediatric Oncology-SIOPEL 2 Eur J Cancer 40 411 421 14746860 1:STN:280:DC%2BD2c%2Fks1WksQ%3D%3D 10.1016/j.ejca.2003.06.003 (Pubitemid 38121279)
49. MLM Poulsen E Budtz-Jørgensen ML Bisgaard 2010 Surveillance in von Hippel-Lindau disease (vHL) Clin Genet 77 49 59 19863552 1:STN:280: DC%2BC3c%2FjvVWrug%3D%3D 10.1111/j.1399-0004.2009.01281.x
50. MH Porteus P Narkool D Neuberg, et al. 2000 Characteristics and outcome of children with Beckwith-Wiedemann syndrome and Wilms' tumor: a report from the national Wilms tumor study group J Clin Oncol 18 2026 2031 10811666 1:STN:280:DC%2BD3c3ntF2qsg%3D%3D (Pubitemid 30324354)
51. M Priesemann KM Davies LA Perry, et al. 2006 Benefits of screening in von Hippel-Lindau disease-comparison of morbidity associated with initial tumours in affected parents and children Horm Res 66 1 5 16651847 1:CAS:528: DC%2BD28XmtVaktb8%3D 10.1159/000093008 (Pubitemid 43952580)
52. F Proust A Laquerriere B Constantin, et al. 1999 Simultaneous presentation of atypical teratoid/rhabdoid tumor in siblings J Neuroncol 43 63 70 1:STN:280:DyaK1Mzns1WjsQ%3D%3D 10.1023/A:1006114732613 (Pubitemid 29351979)
53. A Rao J Rothman KE Nichols 2008 Genetic testing and tumor surveillance for children with cancer predisposition syndromes Curr Opin Pediatr 20 1 7 18197032 10.1097/MOP.0b013e3282f4249a
54. D Reisman S Glaros EA Thompson 2009 The SWI/SNF complex and cancer Oncogene 28 1653 1668 19234488 1:CAS:528:DC%2BD1MXktFOit70%3D 10.1038/onc.2009.4
55. Ries LAG, Smith MA, Gurney JG et al. editors (1999) Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995. Bethesda (MD): National Cancer Institute, SEER Program NIH Pub. No. 99-4649
56. LB Rorke RJ Packer JA Biegel 1996 Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity J Neurosurg 85 56 65 8683283 1:STN:280:DyaK283otF2gtg%3D%3D 10.3171/jns.1996.85.1. 0056 (Pubitemid 26195038)
57. Schimke RN, Collins DL, Stolle CA (2009) von Hippel-Lindau syndrome. GeneReviews. http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part= vhl. Accessed 15 July 2010
58. N Sévenet E Sheridan D Amram, et al. 1999 Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancer Am J Hum Genet 65 1342 1348 10521299 10.1086/302639 (Pubitemid 30460384)
59. TP Slavin GL Wiesner 2009 Developmental defects and childhood cancer Curr Opin Pediatr 21 717 723 19812499 10.1097/MOP.0b013e328332c612
60. B Strahm D Malkin 2006 Hereditary cancer predisposition in children: genetic basis and clinical implications Int J Cancer 119 2001 2006 16642469 1:CAS:528:DC%2BD28XhtVSks7bK 10.1002/ijc.21962 (Pubitemid 44423655)
61. JJ Swensen J Keyser CM Coffin, et al. 2009 Familial occurrence of schwannomas and malignant rhabdoid tumour associated with a duplication in SMARCB1 J Med Genet 46 68 72 19124645 1:CAS:528:DC%2BD1MXitFCqurs%3D 10.1136/jmg.2008.060152
62. U Tabori D Malkin 2008 Risk stratification in cancer predisposition syndromes: lessons learned from novel molecular developments in Li-Fraumeni syndrome Cancer Res 68 2053 2057 18381406 1:CAS:528:DC%2BD1cXktVyqtLY%3D 10.1158/0008-5472.CAN-07-2091 (Pubitemid 351521773)
63. TY Tan DJ Amor 2006 Tumour surveillance in Beckwith-Wiedemann syndrome and hemihyperplasia: a critical review of the evidence and suggested guidelines for local practice J Paediatr Child Health 42 486 490 16925531 10.1111/j.1440-1754.2006.00908.x (Pubitemid 44252516)
64. GE Tomlinson NE Breslow J Dome, et al. 2005 Rhabdoid tumor of the kidney in the National Wilms' Tumor Study: age at diagnosis as a prognostic factor J Clin Oncol 23 7641 7645 16234525 10.1200/JCO.2004.00.8110 (Pubitemid 46291828)
65. JM Varley 2003 Germline TP53 mutations and Li-Fraumeni syndrome Hum Mutat 21 313 320 12619118 1:CAS:528:DC%2BD3sXis1yjtLc%3D 10.1002/humu.10185 (Pubitemid 36292974)
66. KH Vousden C Prives 2009 Blinded by the light: The growing complexity of p53 Cell 137 413 431 19410540 1:CAS:528:DC%2BD1MXlvFams74%3D 10.1016/j.cell.2009.04.037
67. R Weksberg J Nishikawa O Caluseriu, et al. 2001 Tumor development in the Beckwith-Wiedemann syndrome is associated with a variety of constitutional molecular 11p15 alterations including imprinting defects of KCNQ1OT1 Hum Mol Genet 10 2989 3000 11751681 1:CAS:528:DC%2BD38XnsVGhtg%3D%3D 10.1093/hmg/10.26.2989 (Pubitemid 34083485)
68. R Weksberg C Shuman A Smith 2005 Beckwith-Wiedemann syndrome Am J Med Genet 137C 12 23 16010676 10.1002/ajmg.c.30058 (Pubitemid 41113659)
69. R Weksberg C Shuman JB Beckwith 2010 Beckwith-Wiedemann syndrome Eur J Hum Genet 18 8 14 19550435 10.1038/ejhg.2009.106
70. YA Zarate R Mena LJ Martin, et al. 2009 Experience with hemihyperplasia and Beckwith-Wiedemann syndrome surveillance protocol Am J Med Genet 149A 1691 1697 19610116 1:CAS:528:DC%2BD1MXhtVekurzJ 10.1002/ajmg.a.32966